GLICLAZIDE LAPL MR gliclazide 60 mg modified release tablet blister pack

מדינה: אוסטרליה

שפה: אנגלית

מקור: Department of Health (Therapeutic Goods Administration)

קנה את זה

מרכיב פעיל:

gliclazide, Quantity: 60 mg

זמין מ:

Lupin Australia Pty Limited

טופס פרצבטיות:

Tablet, modified release

הרכב:

Excipient Ingredients: povidone; calcium hydrogen phosphate dihydrate; magnesium stearate; hypromellose

מסלול נתינה (של תרופות):

Oral

יחידות באריזה:

60 tablets, 20 tablets

סוג מרשם:

(S4) Prescription Only Medicine

סממני תרפויטית:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

leaflet_short:

Visual Identification: White to off-white oval shaped, bioconvex, uncoated tablet with a break line on both sides and debossed wtih 60 on one side of the break line on one surface.and plain on the other side; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

מצב אישור:

Registered

תאריך אישור:

2022-11-14